Abbreviations

Abbreviations

GMB

Adult glioblastoma

pHGG

Paediatric high-grade glioma

UNCAN

EU initiative for understanding cancer

MRI

Magnetic resonance imaging 

SOC

Standard of care

I/O

Immuno-oncology

TTF

Tumour treating fields

International Day of Women and Girls in Science 2025

On the 10th anniversary of the International Day of Women and Girls in Science, GLIOMATCH celebrates the women driving our research and our commitment to gender balance in science and leadership.

Advancing Women in Science: Charting Progress to Shape the Future

On 11 February 2025, the International Day of Women and Girls in Science marks its 10th anniversary under the theme “Charting Progress to Shape the Future”. This milestone serves as a reminder of the critical contributions of women in research and the need for continued efforts toward inclusivity in STEM. While progress has been made, gender disparities persist, particularly in leadership roles and research participation. Initiatives worldwide aim to address these gaps and support the next generation of female scientists. More on these efforts can be found here.

GLIOMATCH: A Commitment to Gender Balance

At GLIOMATCH, we know that diverse teams drive better science. We are committed to ensuring that our studies accurately reflect gender differences, so our research findings are as robust and meaningful as possible. By accounting for the higher incidence of glioblastoma (GBM) in men, we make sure our data analysis and predictions lead to better outcomes for all patients, regardless of gender, socio-economic status, or ethnic background.

The female faces behind GLIOMATCH

Gender balance in our teams is just as important as in our research. We are proud to have strong female leadership in our consortium, including Prof. Sandra Jacobs (KUL-UZL), Prof. Rachel Grossman (RMC), Dr. Marica Eoli (FINCB), Dr. Géraldine Giraud (UU), Dr. Kathrin Creswell (UEDIN), Dr. Jeanette Müller (accelCH), and Ms. Antonella Cardone (CPE).

Today, we especially want to thank and celebrate all the brilliant women who contribute to GLIOMATCH—from team leaders to researchers and all those driving our work forward. Their expertise is essential in advancing glioblastoma research and improving clinical outcomes for adults and children through tailored immunotherapy treatments.

What Inspires our Researchers?

On this occasion, we asked two female researchers within GLIOMATCH to share one of their favourite quotes about science that has inspired them on their journey.

Dr. Julie Morscio  (KUL-LISCO)

“Science is not a boy’s game, it’s not a girl’s game. It’s everyone’s game. It’s about where we are and where we’re going.”  

Nichelle Nichols

“Science is not about control. It is about cultivating a perpetual condition of wonder in the face of something that forever grows one step richer and subtler than our latest theory about it. It is about reverence, not mastery.”

– Richard Powers

Dr. Chiara Caprioli  (KUL-LISCO)

Meet the teams and talented women behind GLIOMATCH on our consortium page.

Follow GLIOMATCH on LinkedIn and Facebook for more information on brain tumour research and updates on our milestones towards improving the clinical outcomes of GBM and pHGG.

More Posts

GLIOMATCH: Explained with Prof. Dr. Sandra Jacobs

In this GLIOMATCH: Explained episode, Prof. Dr. Sandra Jacobs introduces the paediatric clinical study, the participating centres and the challenges of working with archived samples from paediatric high-grade glioma patients.

GLIOMATCH marks World Brain Tumour Day at EU event on advancing brain cancer research

On World Brain Tumour Day 2026, GLIOMATCH participated in the European event “Advancing Brain Cancer Research: From policy action to scientific breakthroughs” at the European Parliament in Strasbourg. The event highlighted the urgent need to accelerate brain cancer research, strengthen European collaboration and turn scientific progress into improved care for patients.

GLIOMATCH: Explained with Prof. Dr. Steven De Vleeschouwer

In this GLIOMATCH: Explained episode, Prof. Dr. Steven De Vleeschouwer introduces the prospective clinical trials, the participating centres and the immunotherapy strategies being investigated to better understand patient response in brain tumours.

GLIOMATCH 5th consortium meeting takes place in Barcelona

On 28–29 April 2026, the GLIOMATCH consortium gathered in Barcelona, Spain, for its fifth consortium meeting, hosted by project partner Sant Joan de Déu Barcelona Children’s Hospital and the Fundació de Recerca Sant Joan de Déu (FSJD).